Compare SKIL & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKIL | ELUT |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.2M | 42.5M |
| IPO Year | 2019 | 2020 |
| Metric | SKIL | ELUT |
|---|---|---|
| Price | $9.83 | $0.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 58.5K | 52.0K |
| Earning Date | 04-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,293,000.00 |
| Revenue This Year | $0.11 | N/A |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.43 | $0.50 |
| 52 Week High | $18.45 | $2.50 |
| Indicator | SKIL | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 73.79 | 33.79 |
| Support Level | $9.51 | $0.51 |
| Resistance Level | $10.28 | $1.13 |
| Average True Range (ATR) | 0.72 | 0.07 |
| MACD | 0.30 | -0.01 |
| Stochastic Oscillator | 96.54 | 16.70 |
Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.